EP1078636A1 — Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
Assigned to Individual · Expires 2001-02-28 · 25y expired
What this patent protects
The present invention relates to a pharmaceutical composition and the method for the preparation thereof, The composition comprises 1.5∼ 6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, calcium chloride…
USPTO Abstract
The present invention relates to a pharmaceutical composition and the method for the preparation thereof, The composition comprises 1.5∼ 6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, calcium chloride, calcium gluconate, and the like, and 3∼ 18% (w/v) of one or more substances selected from hydroxyethylstarch, dextran, carboxymethylstarch, polyvinyl--pyrrolidone, gelatin derivatives, and the like as well as the remainder of conventional injections, as long as sodium chloride is not less than 1.5% (w/v). The pharmaceutical composition of the present invention is used to treat and save the wounded and patients, as well as to treat shock, its advantages include safe and convenient use, rapid and good curative effect, long time maintenance, extensive uses and the like.
Drugs covered by this patent
- Lasix (furosemide) · Generic (originally Hoechst AG)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.